Earnings Summary

Roivant Sciences Ltd.’s revenue fell -87.94% since last year same period to $4.47Mn in the Q3 2024. On a quarterly growth basis, Roivant Sciences Ltd. has generated -91.88% fall in its revenue since last 3-months.

Roivant Sciences Ltd.’s net profit jumped 24.36% since last year same period to $-230.18Mn in the Q3 2024. On a quarterly growth basis, Roivant Sciences Ltd. has generated -341.54% fall in its net profits since last 3-months.

Roivant Sciences Ltd.’s net profit margin fell -527.09% since last year same period to -5143.78% in the Q3 2024. On a quarterly growth basis, Roivant Sciences Ltd. has generated -3075.82% fall in its net profit margins since last 3-months.

Roivant Sciences Ltd.’s price-to-earnings ratio after this Q3 2024 earnings stands at 2.26.

Roivant Sciences Ltd.’s earning per share (EPS) estimates for the current quarter stand at -0.26 - a 0% jump from last quarter’s estimates.

Roivant Sciences Ltd.’s earning per share (EPS) estimates for the current year stand at -0.26.

Roivant Sciences Ltd.’s earning per share (EPS) jumped 21.75% since last year same period to -0.31 in the Q3 2024. This indicates that the Roivant Sciences Ltd. has generated 21.75% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Roivant Sciences Ltd.’s return on assets (ROA) stands at -0.18.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Roivant Sciences Ltd.’s return on equity (ROE) stands at 1.29.